Drugs
April 2005: Additions and Deletions to the Drug Product List
24th Edition: Cumulative Supplement Number 4: April 2005
[Prescription - OTC]
NOTE: The format for the Monthly Additions/Deletions Drug Product List has changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.5 CUMULATIVE SUPPLEMENT LEGEND.
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
ADENOSINE INJECTABLE; INJECTION ADENSOINE >A> AP AM PHARM 3MG/ML N77133 001 Apr 27, 2005 Apr NEWA ALBUTEROL SULFATE TABLET; ORAL ALBUTEROL SULFATE >A> AB + MYLAN EQ 2MG BASE N72894 002 Jan 17, 1991 Apr CMS1 ALENDRONATE SODIUM SOLUTION; ORAL FOSAMAX >D> + MERCK EQ 70MG ACID/75ML N21575 001 Sep 17, 2003 Apr CPOT >A> + EQ 70MG BASE/75ML N21575 001 Sep 17, 2003 Apr CPOT ALENDRONATE SODIUM; CHOLECALCIFEROL TABLET; ORAL FOSAMAX PLUS D >A> + MERCK EQ 70MG BASE;2,800 IU N21762 001 Apr 07, 2005 Apr NEWA ALPROSTADIL INJECTABLE; INJECTION EDEX >D> + SCHWARZ PHARMA 0.01MG/VIAL N20649 005 Jul 30, 1998 Apr CTEC >A> AP + 0.01MG/VIAL N20649 005 Jul 30, 1998 Apr CTEC >D> + 0.02MG/VIAL N20649 006 Jul 30, 1998 Apr CTEC >A> AP + 0.02MG/VIAL N20649 006 Jul 30, 1998 Apr CTEC >D> + 0.04MG/VIAL N20649 007 Jul 30, 1998 Apr CTEC >A> AP + 0.04MG/VIAL N20649 007 Jul 30, 1998 Apr CTEC AMOXICILLIN FOR SUSPENSION; ORAL TRIMOX >D> @ APOTHECON 50MG/ML N61886 001 Apr CMFD >A> AB 50MG/ML N61886 001 Apr CMFD >D> @ 125MG/5ML N61886 002 Apr CMFD >A> AB 125MG/5ML N61886 002 Apr CMFD >D> @ 250MG/5ML N61886 003 Apr CMFD >A> AB 250MG/5ML N61886 003 Apr CMFD BECLOMETHASONE DIPROPIONATE AEROSOL, METERED; INHALATION >D> VANCERIL >D> + SCHERING 0.042MG/INH N17573 001 Apr DISC >A> @ 0.042MG/INH N17573 001 Apr DISC BETHANECHOL CHLORIDE TABLET; ORAL DUVOID >D> @ WELLSPRING 50MG N85882 003 Apr CMFD >A> AA 50MG N85882 003 Apr CMFD BUTENAFINE HYDROCHLORIDE CREAM; TOPICAL MENTAX >D> + BERTEK PHARMS 1% N20524 001 Oct 18, 1996 Apr CAHN >A> + MYLAN BERTEK 1% N20524 001 Oct 18, 1996 Apr CAHN CEFACLOR FOR SUSPENSION; ORAL >D> CECLOR >D> AB CEPH INTL EQ 125MG BASE/5ML N62206 001 Apr CTNA >D> AB CEPH INTL EQ 187MG BASE/5ML N62206 003 Apr 20, 1988 Apr CTNA >D> AB EQ 250MG BASE/5ML N62206 002 Apr CTNA >D> AB EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Apr CTNA >A> CEFACLOR >A> AB CEPH INTL EQ 125MG BASE/5ML N62206 001 Apr CTNA >A> AB EQ 187MG BASE/5ML N62206 003 Apr 20, 1988 Apr CTNA >A> AB EQ 250MG BASE/5ML N62206 002 Apr CTNA >A> AB EQ 375MG BASE/5ML N62206 004 Apr 20, 1988 Apr CTNA CEFADROXIL/CEFADROXIL HEMIHYDRATE TABLET; ORAL CEFADROXIL >D> @ IVAX PHARMS EQ 1GM BASE N62774 001 Apr 08, 1987 Apr CMFD >A> AB EQ 1GM BASE N62774 001 Apr 08, 1987 Apr CMFD CEFAZOLIN SODIUM INJECTABLE; INJECTION CEFAZOLIN SODIUM >A> AP ORCHID HLTHCARE EQ 500MG BASE/VIAL N65226 001 Apr 21, 2005 Apr NEWA >A> AP EQ 1GM BASE/VIAL N65226 002 Apr 21, 2005 Apr NEWA CEFTRIAXONE SODIUM INJECTABLE; IM-IV CEFTRIAXONE >A> AP SANDOZ EQ 250MG BASE/VIAL N65169 001 May 09, 2005 Apr NEWA >A> AP EQ 500MG BASE/VIAL N65169 002 May 09, 2005 Apr NEWA >A> AP EQ 1GM BASE/VIAL N65169 003 May 09, 2005 Apr NEWA >A> AP EQ 2GM BASE/VIAL N65169 004 May 09, 2005 Apr NEWA INJECTABLE; INJECTION >A> CEFTRIAXONE >A> AP SANDOZ EQ 1GM BASE/VIAL N65204 001 May 03, 2005 Apr NEWA >A> AP EQ 2GM BASE/VIAL N65204 002 May 03, 2005 Apr NEWA >A> AP EQ 10GM BASE/VIAL N65168 001 May 17, 2005 Apr NEWA >A> CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER >A> AP + B BRAUN EQ 1GM BASE/VIAL N50796 001 Apr 20, 2005 Apr NEWA >A> AP + EQ 2GM BASE/VIAL N50796 002 Apr 20, 2005 Apr NEWA ROCEPHIN >D> HLR EQ 250MG BASE/VIAL N63239 001 Aug 13, 1993 Apr DISC >A> @ EQ 250MG BASE/VIAL N63239 001 Aug 13, 1993 Apr DISC >D> EQ 500MG BASE/VIAL N63239 002 Aug 13, 1993 Apr DISC >A> @ EQ 500MG BASE/VIAL N63239 002 Aug 13, 1993 Apr DISC >D> EQ 1GM BASE/VIAL N63239 003 Aug 13, 1993 Apr DISC >A> @ EQ 1GM BASE/VIAL N63239 003 Aug 13, 1993 Apr DISC >D> + EQ 1GM BASE/VIAL N62654 002 Apr 30, 1987 Apr CFTG >A> AP + EQ 1GM BASE/VIAL N62654 002 Apr 30, 1987 Apr CFTG >D> EQ 2GM BASE/VIAL N62654 003 Apr 30, 1987 Apr CFTG >A> AP + EQ 2GM BASE/VIAL N62654 003 Apr 30, 1987 Apr CFTG >D> + EQ 10GM BASE/VIAL N50585 005 Dec 21, 1984 Apr CFTG >A> AP + EQ 10GM BASE/VIAL N50585 005 Dec 21, 1984 Apr CFTG CEFUROXIME SODIUM INJECTABLE; INJECTION CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER >D> + B BRAUN EQ 15MG BASE/ML N50780 001 Feb 21, 2001 Apr CPOT >A> AP + EQ 750MG BASE/VIAL N50780 001 Feb 21, 2001 Apr CPOT >D> + EQ 30MG BASE/ML N50780 002 Feb 21, 2001 Apr CPOT >A> AP + EQ 1.5GM BASE/VIAL N50780 002 Feb 21, 2001 Apr CPOT CHLORPROMAZINE HYDROCHLORIDE TABLET; ORAL CHLORPROMAZINE HCL >D> BP SANDOZ 10MG N80439 001 Apr CRLD >A> BP + 10MG N80439 001 Apr CRLD >D> BP 100MG N80439 004 Apr CRLD >A> BP + 100MG N80439 004 Apr CRLD >D> THORAZINE >D> BP + GLAXOSMITHKLINE 10MG N09149 002 Apr DISC >A> @ 10MG N09149 002 Apr DISC >D> BP 25MG N09149 007 Apr DISC >A> @ GLAXOSMITHKLINE 25MG N09149 007 Apr DISC >D> BP 50MG N09149 013 Apr DISC >A> @ 50MG N09149 013 Apr DISC >D> BP + 100MG N09149 018 Apr DISC >A> @ 100MG N09149 018 Apr DISC >D> BP 200MG N09149 020 Apr DISC >A> @ 200MG N09149 020 Apr DISC CILOSTAZOL TABLET; ORAL CILOSTAZOL >A> AB ROXANE 50MG N77024 001 May 17, 2005 Apr NEWA >A> AB 100MG N77024 002 May 17, 2005 Apr NEWA CITALOPRAM HYDROBROMIDE TABLET; ORAL CITALOPRAM HYDROBROMIDE >A> AB AKYMA PHARMS EQ 10MG BASE N77045 003 Apr 29, 2005 Apr NEWA >A> AB EQ 20MG BASE N77045 002 Apr 29, 2005 Apr NEWA >A> AB EQ 40MG BASE N77045 001 Apr 29, 2005 Apr NEWA CLARITHROMYCIN TABLET, EXTENDED RELEASE; ORAL CLARITHROMYCIN >A> AB TEVA 500MG N65154 001 May 18, 2005 Apr NEWA CLONAZEPAM TABLET; ORAL CLONAZEPAM >A> AB KALI LABS 0.5MG N77147 001 May 02, 2005 Apr NEWA >A> AB 1MG N77147 002 May 02, 2005 Apr NEWA >A> AB 2MG N77147 003 May 02, 2005 Apr NEWA CLOZAPINE TABLET; ORAL CLOZAPINE >A> IVAX PHARMS 50MG N74949 004 Apr 25, 2005 Apr NEWA >A> AB TEVA 25MG N75162 001 Apr 26, 2005 Apr NEWA >A> AB 100MG N75162 002 Apr 26, 2005 Apr NEWA DALTEPARIN SODIUM >D> INJECTABLE; INJECTION >D> FRAGMIN >A> @ PHARMACIA AND 7,500 IU/0.75ML N20287 008 Apr 04, 2002 Apr DISC >A> + 95,000IU/3.8ML(25,000IU/ML) N20287 006 Apr 04, 2002 Apr NEWA >A> + 95,000IU/9.5ML(10,000IU/ML) N20287 007 Apr 04, 2002 Apr NEWA DEXAMETHASONE SODIUM PHOSPHATE INJECTABLE; INJECTION DEXAMETHASONE SODIUM PHOSPHATE >A> AP AM PHARM EQ 10MG PHOSPHATE/ML N40572 001 Apr 22, 2005 Apr NEWA DIAZEPAM GEL; RECTAL DIASTAT >A> VALEANT 2.5MG/0.5ML N20648 001 Jul 29, 1997 Apr CAHN >A> 5MG/ML N20648 002 Jul 29, 1997 Apr CAHN >A> 10MG/2ML N20648 003 Jul 29, 1997 Apr CAHN >A> 15MG/3ML N20648 004 Jul 29, 1997 Apr CAHN >A> + 20MG/4ML N20648 005 Jul 29, 1997 Apr CAHN >D> XCEL PHARMS 2.5MG/0.5ML N20648 001 Jul 29, 1997 Apr CAHN >D> 5MG/ML N20648 002 Jul 29, 1997 Apr CAHN >D> 10MG/2ML N20648 003 Jul 29, 1997 Apr CAHN >D> 15MG/3ML N20648 004 Jul 29, 1997 Apr CAHN >D> + 20MG/4ML N20648 005 Jul 29, 1997 Apr CAHN DIHYDROERGOTAMINE MESYLATE INJECTABLE; INJECTION D.H.E. 45 >A> AP + VALEANT 1MG/ML N05929 001 Apr CAHN >D> AP + XCEL PHARMS 1MG/ML N05929 001 Apr CAHN SPRAY, METERED; NASAL MIGRANAL >A> + VALEANT 0.5MG/INH N20148 001 Dec 08, 1997 Apr CAHN >D> + XCEL PHARM 0.5MG/INH N20148 001 Dec 08, 1997 Apr CAHN DOXYCYCLINE HYCLATE CAPSULE; ORAL DOXYCYCLINE HYCLATE >A> + WEST WARD EQ 20MG BASE N65103 001 May 13, 2005 Apr NEWA TABLET; ORAL DOXYCYCLINE HYCLATE >A> AB COREPHARMA EQ 20MG BASE N65182 001 May 13, 2005 Apr NEWA >A> AB IVAX PHARMS EQ 20MG BASE N65163 001 May 13, 2005 Apr NEWA >A> AB MUTUAL PHARMA EQ 20MG BASE N65134 001 May 13, 2005 Apr NEWA PERIOSTAT >D> + COLLAGENEX 20MG N50783 001 Feb 02, 2001 Apr CFTG >A> AB + EQ 20MG BASE N50783 001 Feb 02, 2001 Apr CFTG ESMOLOL HYDROCHLORIDE INJECTABLE; INJECTION ESMOLOL HCL >A> AP AM PHARM 10MG/ML N76573 001 May 02, 2005 Apr NEWA >A> AP PHARMAFORCE 10MG/ML N76474 001 May 02, 2005 Apr NEWA ESTRADIOL; NORGESTIMATE TABLET; ORAL >A> ESTRADIOL AND NORGESTIMATE >A> AB BARR 1MG,1MG;N/A,0.09MG N76812 001 Apr 29, 2005 Apr NEWA PREFEST >D> + DURAMED 1MG,1MG;0.09MG,N/A N21040 001 Oct 22, 1999 Apr CFTG >A> AB + 1MG,1MG;N/A,0.09MG N21040 001 Oct 22, 1999 Apr CFTG ETHINYL ESTRADIOL; NORETHINDRONE ACETATE TABLET; ORAL-28 NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE >A> AB ANDRX PHARMS 0.03MG;1.5MG N77075 001 Apr 28, 2005 Apr NEWA >A> EXENATIDE SYNTHETIC >A> INJECTABLE; SUBCUTANEOUS >A> BYETTA >A> + AMYLIN 300UGM/1.2ML(250UGM/ML) N21773 001 Apr 28, 2005 Apr NEWA >A> + 600UGM/2.4ML(250UGM/ML) N21773 002 Apr 28, 2005 Apr NEWA FETABLET; ORAL >A> AB FETEVA 54MG N76433 001 May 13, 2005 Apr NEWA >A> AB 160MG N76433 002 May 13, 2005 Apr NEWA TRICOR >D> ABBOTT 54MG N21203 001 Sep 04, 2001 Apr CFTG >A> AB 54MG N21203 001 Sep 04, 2001 Apr CFTG >D> + 160MG N21203 003 Sep 04, 2001 Apr CFTG >A> AB + 160MG N21203 003 Sep 04, 2001 Apr CFTG FENOPROFEN CALCIUM CAPSULE; ORAL NALFON >A> AB + PEDINOL EQ 300MG BASE N17604 002 Apr CAHN >D> AB + RANBAXY EQ 300MG BASE N17604 002 Apr CAHN NALFON 200 >A> AB PEDINOL EQ 200MG BASE N17604 003 Apr CAHN >D> AB RANBAXY EQ 200MG BASE N17604 003 Apr CAHN FLUCYTOSINE CAPSULE; ORAL ANCOBON >D> ICN 250MG N17001 001 Apr CAHN >D> + 500MG N17001 002 Apr CAHN >A> VALEANT 250MG N17001 001 Apr CAHN >A> + 500MG N17001 002 Apr CAHN FLUMAZENIL INJECTABLE; INJECTION FLUMAZENIL >A> AP SABEX 2002 0.5MG/5ML (0.1MG/ML) N77071 001 May 03, 2005 Apr NEWA >A> AP 1MG/10ML (0.1MG/ML) N77071 002 May 03, 2005 Apr NEWA FLUOCINOLONE ACETONIDE >A> IMPLANT; INTRAVITREAL >A> RETISERT >A> + BAUSCH AND LOMB 0.59MG N21737 001 Apr 08, 2005 Apr NEWA FLUOROURACIL INJECTABLE; INJECTION FLUOROURACIL >D> AP + ICN PUERTO RICO 50MG/ML N12209 001 Apr CAHN >A> AP + VALEANT 50MG/ML N12209 001 Apr CAHN FLUOXETINE HYDROCHLORIDE CAPSULE; ORAL FLUOXETINE >A> AB BARR EQ 40MG BASE N76251 001 May 18, 2005 Apr NEWA FOSINOPRIL SODIUM TABLET; ORAL FOSINOPRIL SODIUM >A> AB APOTEX 10MG N76906 001 May 17, 2005 Apr NEWA >A> AB 20MG N76906 002 May 17, 2005 Apr NEWA >A> AB 40MG N76906 003 May 17, 2005 Apr NEWA GABAPENTIN TABLET; ORAL GABAPENTIN >A> AB IVAX PHARMS 600MG N76017 004 Apr 29, 2005 Apr NEWA >A> AB 800MG N76017 005 Apr 29, 2005 Apr NEWA GLYCOPYRROLATE TABLET; ORAL GLYCOPYRROLATE >D> AB COREPHARMA 1MG N40568 001 Dec 22, 2004 Apr CTEC >A> AA 1MG N40568 001 Dec 22, 2004 Apr CTEC >D> AB 2MG N40568 002 Dec 22, 2004 Apr CTEC >A> AA 2MG N40568 002 Dec 22, 2004 Apr CTEC ROBINUL >D> AB + FIRST HORIZON 1MG N12827 001 Apr CTEC >A> AA + 1MG N12827 001 Apr CTEC ROBINUL FORTE >D> AB + FIRST HORIZON 2MG N12827 002 Apr CTEC >A> AA + 2MG N12827 002 Apr CTEC HYDROCHLOROTHIAZIDE TABLET; ORAL HYDROCHLOROTHIAZIDE >D> AB IVAX PHARMS 50MG N83177 002 Apr CRLD >A> AB + 50MG N83177 002 Apr CRLD >D> AB + 100MG N85022 001 Apr DISC >A> @ 100MG N85022 001 Apr DISC IBANDRONATE SODIUM TABLET; ORAL BONIVA >D> ROCHE EQ 150MG BASE N21455 002 Mar 24, 2005 Apr CRLD >A> + EQ 150MG BASE N21455 002 Mar 24, 2005 Apr CRLD IPRATROPIUM BROMIDE SOLUTION; INHALATION IPRATROPIUM BROMIDE >A> AN BREATH LTD 0.02% N76291 001 May 09, 2005 Apr NEWA LEUCOVORIN CALCIUM INJECTABLE; INJECTION LEUCOVORIN CALCIUM PRESERVATIVE FREE >D> AP BEDFORD EQ 10MG BASE/ML N40347 001 Apr 25, 2000 Apr CRLD >A> AP + EQ 10MG BASE/ML N40347 001 Apr 25, 2000 Apr CRLD >D> AP + HOSPIRA EQ 10MG BASE/ML N40147 001 Jun 25, 1997 Apr DISC >A> @ EQ 10MG BASE/ML N40147 001 Jun 25, 1997 Apr DISC LIDOCAINE HYDROCHLORIDE INJECTABLE; INJECTION LIDOCAINE HCL PRESERVATIVE FREE >A> AP AM PHARM 2% N17584 001 Apr CAHN >A> AP 4% N17584 002 Apr CAHN >D> AP AM PHARM PARTNERS 2% N17584 001 Apr CAHN >D> AP 4% N17584 002 Apr CAHN MAFENIDE ACETATE CREAM; TOPICAL SULFAMYLON >D> + BERTEK PHARMS EQ 85MG BASE/GM N16763 001 Apr CAHN >A> + MYLAN BERTEK EQ 85MG BASE/GM N16763 001 Apr CAHN MEMANTINE HYDROCHLORIDE >A> SOLUTION; ORAL >A> NAMENDA >A> + FOREST LABS 2MG/ML N21627 001 Apr 18, 2005 Apr NEWA METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL METFORMIN HCL >A> AB ZYDUS PHARMS USA 750MG N77078 001 Apr 21, 2005 Apr NEWA METHIMAZOLE TABLET; ORAL METHIMAZOLE >D> AB + GENPHARM 20MG N40350 003 Jun 07, 2001 Apr DISC >A> @ 20MG N40350 003 Jun 07, 2001 Apr DISC METHOTREXATE SODIUM INJECTABLE; INJECTION METHOTREXATE >D> AP BIGMAR BIOREN EQ 25MG BASE/ML N40263 001 Feb 26, 1999 Apr DISC >A> @ EQ 25MG BASE/ML N40263 001 Feb 26, 1999 Apr DISC >A> AP + MAYNE PHARMA USA EQ 50MG BASE/2ML (25 MG/ML) N11719 010 Dec 15, 2004 Apr NEWA METHOTREXATE LPF >D> AP + MAYNE PHARMA USA EQ 25MG BASE/ML N11719 007 Mar 31, 1982 Apr DISC >A> @ EQ 25MG BASE/ML N11719 007 Mar 31, 1982 Apr DISC METHOTREXATE PRESERVATIVE FREE >D> AP BIGMAR BIOREN EQ 25MG BASE/ML N40265 001 Feb 26, 1999 Apr DISC >A> @ EQ 25MG BASE/ML N40265 001 Feb 26, 1999 Apr DISC >D> AP EQ 1GM BASE/VIAL N40266 001 Feb 26, 1999 Apr DISC >A> @ EQ 1GM BASE/VIAL N40266 001 Feb 26, 1999 Apr DISC >A> + MAYNE PHARMA USA EQ 20MG BASE/2ML (10 MG/ML) N11719 014 Apr 13, 2005 Apr NEWA >A> AP + EQ 500MG BASE/20ML (25 MG/ML) N11719 013 Apr 13, 2005 Apr NEWA >A> AP + ED 1GM BASE/40ML (25 MG/ML) N11719 012 Apr 13, 2005 Apr NEWA >A> AP + EQ 2.5GM BASE/100ML (25 MG/ML) N11719 011 Apr 13, 2005 Apr NEWA METHOTREXATE SODIUM >D> AP BEDFORD EQ 25MG BASE/ML N89340 001 Sep 16, 1986 Apr CPOT >A> AP EQ 50 MG BASE/2ML (25 ML/ML) N89340 001 Sep 16, 1986 Apr CPOT >D> AP EQ 25MG BASE/ML N89341 001 Sep 16, 1986 Apr CPOT >A> AP EQ 100MG BASE/4ML (25 MG/ML) N89341 001 Sep 16, 1986 Apr CPOT >D> AP EQ 25MG BASE/ML N89342 001 Sep 16, 1986 Apr CPOT >A> AP EQ 200MG BASE/8ML (25 MG/ML) N89342 001 Sep 16, 1986 Apr CPOT >D> AP EQ 25MG BASE/ML N89343 001 Sep 16, 1986 Apr CPOT >A> AP EQ 250MG BASE/10ML (25 MG/ML) N89343 001 Sep 16, 1986 Apr CPOT >D> AP + MAYNE PHARMA USA EQ 25MG BASE/ML N11719 005 Apr DISC >A> @ EQ 25MG BASE/ML N11719 005 Apr DISC >D> AP NORBROOK EQ 25MG BASE/ML N88648 001 May 09, 1986 Apr DISC >A> @ EQ 25MG BASE/ML N88648 001 May 09, 1986 Apr DISC >D> AP PHARMACHEMIE USA EQ 25MG BASE/ML N89158 001 Jul 08, 1988 Apr DISC >A> @ EQ 25MG BASE/ML N89158 001 Jul 08, 1988 Apr DISC MEXATE-AQ >D> AP BRISTOL MYERS EQ 25MG BASE/ML N88760 001 Feb 14, 1985 Apr DISC >A> @ EQ 25MG BASE/ML N88760 001 Feb 14, 1985 Apr DISC MIDAZOLAM HYDROCHLORIDE SYRUP; ORAL MIDAZOLAM HCL >A> AA PADDOCK EQ 2MG BASE/ML N76379 001 May 02, 2005 Apr NEWA MOMETASONE FUROATE MONOHYDRATE SPRAY, METERED; NASAL NASONEX >A> + SCHERING PLOUGH EQ 0.05MG BASE/SPRAY N20762 001 Oct 01, 1997 Apr CAHN >D> + SHIRE EQ 0.05MG BASE/SPRAY N20762 001 Oct 01, 1997 Apr CAHN NAPROXEN TABLET; ORAL NAPROXEN >A> AB PERRIGO R AND D 250MG N77339 001 Apr 27, 2005 Apr NEWA >A> AB 375MG N77339 002 Apr 27, 2005 Apr NEWA >A> AB 500MG N77339 003 Apr 27, 2005 Apr NEWA >D> NESIRITIDE >D> FOR SOLUTION; INTRAVENOUS >D> NATRECOR >D> + SCIOS 1.5MG/VIAL N20920 001 Aug 10, 2001 Apr CAIN >A> NESIRITIDE RECOMBINANT >A> FOR SOLUTION; INTRAVENOUS >A> NATRECOR >A> + SCIOS 1.5MG/VIAL N20920 001 Aug 10, 2001 Apr CAIN NIACIN TABLET, EXTENDED RELEASE; ORAL >A> NIACIN >A> AB BARR 500MG N76378 001 Apr 26, 2005 Apr NEWA >A> AB 750MG N76378 002 Apr 26, 2005 Apr NEWA NIASPAN >D> + KOS 500MG N20381 002 Jul 28, 1997 Apr CFTG >A> AB + 500MG N20381 002 Jul 28, 1997 Apr CFTG >D> + 750MG N20381 003 Jul 28, 1997 Apr CFTG >A> AB + 750MG N20381 003 Jul 28, 1997 Apr CFTG NYSTATIN POWDER; TOPICAL NYSTATIN >A> AT UPSHER SMITH 100,000 UNITS/GM N65183 001 May 03, 2005 Apr NEWA OMEPRAZOLE CAPSULE, DELAYED REL PELLETS; ORAL PRILOSEC >D> ASTRAZENECA 40MG N19810 002 Jan 15, 1998 Apr CRLD >A> + 40MG N19810 002 Jan 15, 1998 Apr CRLD OXAZEPAM CAPSULE; ORAL OXAZEPAM >D> AB IVAX PHARMS 30MG N70945 001 Aug 03, 1987 Apr CRLD >A> AB + 30MG N70945 001 Aug 03, 1987 Apr CRLD >D> SERAX >D> AB ALPHARMA US 10MG N15539 002 Apr DISC >A> @ 10MG N15539 002 Apr DISC >D> AB 15MG N15539 004 Apr DISC >A> @ 15MG N15539 004 Apr DISC >D> AB + 30MG N15539 006 Apr DISC >A> @ 30MG N15539 006 Apr DISC PREDNISOLONE SODIUM PHOSPHATE SOLUTION; ORAL PREDNISOLONE SODIUM PHOSPHATE >A> AA PHARM ASSOC EQ 15MG BASE/5ML N76913 001 Apr 25, 2005 Apr NEWA PRIMIDONE TABLET; ORAL MYSOLINE >A> AB + VALEANT 50MG N09170 003 Apr CAHN >A> AB 250MG N09170 002 Apr CAHN >D> AB + XCEL PHARMS 50MG N09170 003 Apr CAHN >D> AB 250MG N09170 002 Apr CAHN PROPRANOLOL HYDROCHLORIDE TABLET; ORAL INDERAL >D> AB + WYETH PHARMS INC 10MG N16418 001 Apr CRLD >A> AB 10MG N16418 001 Apr CRLD THEOPHYLLINE CAPSULE, EXTENDED RELEASE; ORAL THEOPHYLLINE >D> BC INWOOD LABS 125MG N40052 002 Feb 14, 1994 Apr CTEC >A> 125MG N40052 002 Feb 14, 1994 Apr CTEC TOLTERODINE TARTRATE CAPSULE, EXTENDED RELEASE; ORAL DETROL LA >D> + PHARMACIA AND 2MG N21228 001 Dec 22, 2000 Apr CRLD >A> 2MG N21228 001 Dec 22, 2000 Apr CRLD
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
BENTOQUATAM LOTION; TOPICAL IVY BLOCK >D> + ENVIRODERM 5% N20532 001 Aug 26, 1996 Apr CAHN >A> + STAND HOMEOPATH 5% N20532 001 Aug 26, 1996 Apr CAHN CHLORHEXIDINE GLUCONATE CLOTH; TOPICAL CHLORHEXIDINE GLUCONATE >A> + SAGE PRODS 2% N21669 001 Apr 25, 2005 Apr NEWA CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL SPONGE; TOPICAL >D> CHLORAPREP ONE-STEP FREPP >D> + MEDI FLEX HOSP 2%;70% N20832 001 Jul 14, 2000 Apr CTNA >A> + MEDI FLEX INC 2%;70% N20832 001 Jul 14, 2000 Apr CTNA >A> CHLORAPREP WITH TINT >A> + MEDI FLEX INC 2%;70% N20832 002 May 03, 2005 Apr NEWA DEXTROMETHORPHAN POLISTIREX SUSPENSION, EXTENDED RELEASE; ORAL DELSYM >D> + CELLTECH PHARMS EQ 30MG HBR/5ML N18658 001 Oct 08, 1982 Apr CAHN >A> + UCB EQ 30MG HBR/5ML N18658 001 Oct 08, 1982 Apr CAHN LOPERAMIDE HYDROCHLORIDE SOLUTION; ORAL IMODIUM A-D >A> + MCNEIL 1MG/7.5ML N19487 002 Jul 08, 2004 Apr NEWA NICOTINE POLACRILEX GUM, CHEWING; BUCCAL >D> NICOTINE POLACRILEX >D> WATSON LABS EQ 2MG BASE N76569 001 Jul 29, 2004 Apr CTNA >D> EQ 2MG BASE N76568 001 Jul 29, 2004 Apr DISC >A> @ EQ 2MG BASE N76568 001 Jul 29, 2004 Apr DISC >D> EQ 4MG BASE N76569 002 Jul 29, 2004 Apr DISC >A> @ EQ 4MG BASE N76569 002 Jul 29, 2004 Apr DISC >D> EQ 4MG BASE N76568 002 Jul 29, 2004 Apr CTNA >A> NICOTINE POLACRILEX (MINT) >A> WATSON LABS EQ 2MG BASE N76569 001 Jul 29, 2004 Apr CTNA >A> EQ 4MG BASE N76568 002 Jul 29, 2004 Apr CTNA